IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FREDERICK PENG

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1730685777
CMS profile
11389091
Location
SUGAR LAND, TX

General Payments · PY2022–2024

$1,952.30

  • Reported across 96 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,117.91

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Gastroenterology TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,117.91 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $374.21 8
Takeda Pharmaceuticals U.S.A., Inc. $203.51 10
Salix Pharmaceuticals, a division of Bausch Health US, LLC $143.87 14
CONMED Corporation $121.07 3
Merck Sharp & Dohme Corporation $75.94 4
INTERCEPT PHARMACEUTICALS, INC. $33.25 2
Ardelyx, Inc. $28.88 2
BOSTON SCIENTIFIC CORPORATION $28.57 1
Janssen Biotech, Inc. $24.81 1
GENZYME CORPORATION $24.21 1
Gilead Sciences, Inc. $22.83 1
Phathom Pharmaceuticals, Inc. $19.03 1
Madrigal Pharmaceuticals $17.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $219.51 12
PY2023 $614.88 35
PY2024 $1,117.91 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $20.50 01/18/2024 Food and Beverage Undisputed 01/23/2026 1105231686 CMS
ABBVIE INC. $123.75 01/22/2024 Food and Beverage Undisputed 01/23/2026 1105231690 CMS
ABBVIE INC. $124.98 02/29/2024 Food and Beverage Undisputed 01/23/2026 1105231694 CMS
ABBVIE INC. $17.81 03/20/2024 Food and Beverage Undisputed 01/23/2026 1105231698 CMS
ABBVIE INC. $24.80 05/02/2024 Food and Beverage Undisputed 01/23/2026 1105231702 CMS
ABBVIE INC. $17.50 06/13/2024 Food and Beverage Undisputed 01/23/2026 1105231706 CMS
ABBVIE INC. $29.61 10/03/2024 Food and Beverage Undisputed 01/23/2026 1105231710 CMS
ABBVIE INC. $15.26 10/10/2024 Food and Beverage Undisputed 01/23/2026 1105231714 CMS
Ardelyx, Inc. $14.12 11/07/2024 Food and Beverage Undisputed 01/23/2026 1146700666 CMS
Ardelyx, Inc. $14.76 12/19/2024 Food and Beverage Undisputed 01/23/2026 1146700668 CMS
Boston Scientific Corporation $28.57 02/27/2024 Food and Beverage Undisputed 01/23/2026 1092616248 CMS
CONMED Corporation $8.80 03/19/2024 Food and Beverage Undisputed 01/23/2026 1142400423 CMS
CONMED Corporation $103.47 04/24/2024 Food and Beverage Undisputed 01/23/2026 1142400425 CMS
CONMED Corporation $8.80 10/09/2024 Food and Beverage Undisputed 01/23/2026 1142400427 CMS
GENZYME CORPORATION $24.21 12/12/2024 Food and Beverage Undisputed 01/23/2026 1139985714 CMS
Gilead Sciences, Inc. $22.83 03/19/2024 Food and Beverage Undisputed 01/23/2026 1133840540 CMS
Intercept Pharmaceuticals, Inc. $13.99 04/30/2024 Food and Beverage Undisputed 01/23/2026 1113633806 CMS
Intercept Pharmaceuticals, Inc. $19.26 06/18/2024 Food and Beverage Undisputed 01/23/2026 1113633804 CMS
Janssen Biotech, Inc. $24.81 10/22/2024 Food and Beverage Undisputed 01/23/2026 1078723123 CMS
Madrigal Pharmaceuticals $17.73 11/13/2024 Food and Beverage Undisputed 01/23/2026 1144178781 CMS
Merck Sharp & Dohme LLC $16.95 02/15/2024 Food and Beverage Undisputed 01/23/2026 1141552950 CMS
Merck Sharp & Dohme LLC $21.02 04/18/2024 Food and Beverage Undisputed 01/23/2026 1141821387 CMS
Merck Sharp & Dohme LLC $21.18 09/18/2024 Food and Beverage Undisputed 01/23/2026 1141552952 CMS
Merck Sharp & Dohme LLC $16.79 11/21/2024 Food and Beverage Undisputed 01/23/2026 1141552954 CMS
Phathom Pharmaceuticals, Inc. $19.03 10/02/2024 Food and Beverage Undisputed 01/23/2026 1151109280 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $0.94 02/21/2024 Food and Beverage Undisputed 01/23/2026 1153731797 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.71 03/06/2024 Food and Beverage Undisputed 01/23/2026 1153567030 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.75 05/30/2024 Food and Beverage Undisputed 01/23/2026 1153553185 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.43 06/06/2024 Food and Beverage Undisputed 01/23/2026 1153665918 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $3.91 07/31/2024 Food and Beverage Undisputed 01/23/2026 1153611809 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.60 08/28/2024 Food and Beverage Undisputed 01/23/2026 1153480816 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $0.25 10/16/2024 Food and Beverage Undisputed 01/23/2026 1153545363 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.80 10/16/2024 Food and Beverage Undisputed 01/23/2026 1153705644 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.46 11/11/2024 Food and Beverage Undisputed 01/23/2026 1153399645 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $4.90 11/13/2024 Food and Beverage Undisputed 01/23/2026 1153543698 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1.61 11/13/2024 Food and Beverage Undisputed 01/23/2026 1153561701 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $0.20 11/27/2024 Food and Beverage Undisputed 01/23/2026 1153605460 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.91 11/27/2024 Food and Beverage Undisputed 01/23/2026 1153672675 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1.40 12/11/2024 Food and Beverage Undisputed 01/23/2026 1153554769 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.21 02/22/2024 Food and Beverage Undisputed 01/23/2026 1137652752 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.41 03/28/2024 Food and Beverage Undisputed 01/23/2026 1137652754 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.90 05/09/2024 Food and Beverage Undisputed 01/23/2026 1137652756 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.52 07/03/2024 Food and Beverage Undisputed 01/23/2026 1137652758 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.32 07/24/2024 Food and Beverage Undisputed 01/23/2026 1137652760 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.30 10/23/2024 Food and Beverage Undisputed 01/23/2026 1137652762 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.27 10/30/2024 Food and Beverage Undisputed 01/23/2026 1137652764 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.92 10/31/2024 Food and Beverage Undisputed 01/23/2026 1137652766 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.47 11/14/2024 Food and Beverage Undisputed 01/23/2026 1137652768 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.19 12/05/2024 Food and Beverage Undisputed 01/23/2026 1137652770 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.